[
  {
    "ts": null,
    "headline": "Davis Opportunity Fund 2025 Semi-Annual Review",
    "summary": "Davis Opportunity Fund returned 9.50% in the first six months of 2025, outperforming its benchmark. Read more here.",
    "url": "https://finnhub.io/api/news?id=c43f682b546edff03d51993ad7be9c63452e6b07c24299515e88d74f14866313",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754951400,
      "headline": "Davis Opportunity Fund 2025 Semi-Annual Review",
      "id": 136313722,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "Davis Opportunity Fund returned 9.50% in the first six months of 2025, outperforming its benchmark. Read more here.",
      "url": "https://finnhub.io/api/news?id=c43f682b546edff03d51993ad7be9c63452e6b07c24299515e88d74f14866313"
    }
  },
  {
    "ts": null,
    "headline": "Tracking Christopher Davis' Davis Selected Advisers 13F Portfolio - Q2 2025 Update",
    "summary": "Tracking Christopher Davis' Davis Selected Advisers 13F Portfolio - Q2 2025 Update",
    "url": "https://finnhub.io/api/news?id=e9dde0be3e9c7edcc68fc9bce5951677a5ebb9247eb1fd21f8fade3db1768f8f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754943475,
      "headline": "Tracking Christopher Davis' Davis Selected Advisers 13F Portfolio - Q2 2025 Update",
      "id": 136313089,
      "image": "",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=e9dde0be3e9c7edcc68fc9bce5951677a5ebb9247eb1fd21f8fade3db1768f8f"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health Corp. stock underperforms Monday when compared to competitors",
    "summary": "CVS Health Corp. stock underperforms Monday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=9dc2faf0cb8883ece75201fac2ac349cab31ea1fe67e88e95cec32b43aad820b",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754930460,
      "headline": "CVS Health Corp. stock underperforms Monday when compared to competitors",
      "id": 136335024,
      "image": "",
      "related": "CVS",
      "source": "MarketWatch",
      "summary": "CVS Health Corp. stock underperforms Monday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=9dc2faf0cb8883ece75201fac2ac349cab31ea1fe67e88e95cec32b43aad820b"
    }
  },
  {
    "ts": null,
    "headline": "CVS or DHR: Which Is the Better Value Stock Right Now?",
    "summary": "CVS vs. DHR: Which Stock Is the Better Value Option?",
    "url": "https://finnhub.io/api/news?id=6e80d3c9c931b2508c2e398c038b40c9d2a09af68b609a7637a2a7b7352a7551",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754926802,
      "headline": "CVS or DHR: Which Is the Better Value Stock Right Now?",
      "id": 136310684,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS vs. DHR: Which Stock Is the Better Value Option?",
      "url": "https://finnhub.io/api/news?id=6e80d3c9c931b2508c2e398c038b40c9d2a09af68b609a7637a2a7b7352a7551"
    }
  },
  {
    "ts": null,
    "headline": "CVS Among 14 Firms to Storm High-Grade Market Before CPI Report",
    "summary": "(Bloomberg) -- CVS Health Corp. and a unit of Chevron Corp. are among 14 firms offering US investment-grade bonds Monday, the most in three months, a day before heavily anticipated consumer-price data is due for release. Most Read from BloombergSunseeking Germans Face Swiss Backlash Over Alpine Holiday CongestionNew York Warns of $34 Billion Budget Hole, Biggest Since 2009 CrisisTo Head Off Severe Storm Surges, Nova Scotia Invests in ‘Living Shorelines’Chicago Schools’ Bond Penalty Widens as $73",
    "url": "https://finnhub.io/api/news?id=4ebdac1b964c7ac4199fe042a9b7bcd25d1b86c34cb417b56eb0ec088abcb80e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754922839,
      "headline": "CVS Among 14 Firms to Storm High-Grade Market Before CPI Report",
      "id": 136310519,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "(Bloomberg) -- CVS Health Corp. and a unit of Chevron Corp. are among 14 firms offering US investment-grade bonds Monday, the most in three months, a day before heavily anticipated consumer-price data is due for release. Most Read from BloombergSunseeking Germans Face Swiss Backlash Over Alpine Holiday CongestionNew York Warns of $34 Billion Budget Hole, Biggest Since 2009 CrisisTo Head Off Severe Storm Surges, Nova Scotia Invests in ‘Living Shorelines’Chicago Schools’ Bond Penalty Widens as $73",
      "url": "https://finnhub.io/api/news?id=4ebdac1b964c7ac4199fe042a9b7bcd25d1b86c34cb417b56eb0ec088abcb80e"
    }
  },
  {
    "ts": null,
    "headline": "3 Reasons to Sell CVS and 1 Stock to Buy Instead",
    "summary": "Over the past six months, CVS Health has been a great trade, beating the S&P 500 by 13.8%. Its stock price has climbed to $65.46, representing a healthy 19% increase. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.",
    "url": "https://finnhub.io/api/news?id=a2b5c1b5e5b762a28e4a39bbf155bd1cbcf8e6cd90c355c15488a5db145a2c12",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754884909,
      "headline": "3 Reasons to Sell CVS and 1 Stock to Buy Instead",
      "id": 136294432,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Over the past six months, CVS Health has been a great trade, beating the S&P 500 by 13.8%. Its stock price has climbed to $65.46, representing a healthy 19% increase. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.",
      "url": "https://finnhub.io/api/news?id=a2b5c1b5e5b762a28e4a39bbf155bd1cbcf8e6cd90c355c15488a5db145a2c12"
    }
  }
]